Keyword: Active Pharmaceutical Ingredients (APIs)

Chemistry & Life Sciences

Understanding the Requirements of Safe HPAPI Manufacturing

11.09.2020 -

The pharmaceutical industry is increasingly focused on the development of specialized drug products with new treatment modalities, including previously undruggable...

Chemistry & Life Sciences

The Impact of Covid-19 on the Pharmaceutical Industry

31.08.2020 -

Andrew Badrot, CEO of C2 Pharma and a close observer of pharma industry trends, analyzes the current situation and how this pandemic may kick of changes in the pharma...

Logistics & Supply Chain

The Risk of Dependency in Pharma Supply Chains

29.05.2020 - In recent decades, outsourcing of production steps, especially to Asia, has been one of the most important trends in manufacturing strategies in both the European and the US...

Chemistry & Life Sciences

Flow Chemistry - A Mature Technology still on the Rise

20.04.2020 -

The change in many chemical companies’ product portfolio away from commodities to customer-specific specialties is one of the current challenges facing the process...

Strategy & Management

Chemical Process Research and Development

20.04.2020 - Increasing demands for outsourced solutions has made contract research organizations (CROs) an important facet of the pharmaceutical landscape. Innovator pharma will regularly...

Strategy & Management

Nanoforming

20.04.2020 -

In 2019, the pharmaceutical industry invested $182 billion in drug development, but only 48 drugs were approved for use.

Chemistry & Life Sciences

Flow Chemistry: A Mature Technology still on the Rise

20.04.2020 -

The change in many chemical companies’ product portfolio away from commodities to customer-specific specialties is one of the current challenges facing the process...

Strategy & Management

Continuous Pharmaceutical Manufacturing

15.04.2020 - The pharmaceutical industry has been slowly, but surely, embrac­ing continuous manufacturing (CM) over the past decade. In fact, most large pharma companies have invested in...